Podchaser Logo
Home
Immune cell therapies and targeted therapies in AML

Immune cell therapies and targeted therapies in AML

Released Friday, 13th October 2023
Good episode? Give it some love!
Immune cell therapies and targeted therapies in AML

Immune cell therapies and targeted therapies in AML

Immune cell therapies and targeted therapies in AML

Immune cell therapies and targeted therapies in AML

Friday, 13th October 2023
Good episode? Give it some love!
Rate Episode

In this podcast, expert Prof Paresh Vyas and host Dr Enrica Orsini delve into the latest developments in the treatment of Acute Myeloid Leukemia (AML). They discuss new drug targets, new therapies in clinics and the impact of the new treatment on aging patients Moreover, they address existing challenges and provide a glimpse into what the future holds for AML treatment.

Guest: Prof Paresh Vyas, University of Oxford, United Kingdom

Host: Dr Enrica Orsini, EHA


Learn More

What did you think of this podcast? Share your opinions with us in this short feedback survey.

Provide Feedback

Would you like to explore more eLearning or podcasts? Please visit the EHA Campus.

https://ehaedu.org/Campus

Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to.

Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/

Facebook: https://e-h-a.link/facebook

LinkedIn: https://www.linkedin.com/company/eha/

Email us: [email protected]

Subscribe to receive the EHA Educational Updates via https://eha.news/subscribe 

Show More

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features